A comprehensive view of Approval Recommendations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Automobile Industry Market Intelligence Service.
'Solid Forms And Combination Compositions Comprising A Beta-Lactamase Inhibitor And Uses Thereof' in Patent Application Approval Process (USPTO 20240101580)
Published:
April 15, 2024
by NewsRx Drug Daily
|
Roche granted FDA Breakthrough Device Designation for Elecsys pTau217 blood test to support earlier Alzheimer's disease diagnosis; the test helps identify the presence or absence of amyloid pathology in individuals
Published:
April 11, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Bristol Myers' Krazati and Eli Lilly's Erbitux show efficacy in Phase 1/2 trial for a rare form of colorectal cancer driven by KRAS G12C gene mutation; FDA expected to make a decision on treatment by June 2024
Published:
April 09, 2024
by SeeNews Pharmaceuticals
|
Novo Nordisk's diabetes treatment Awiqli gets positive CHMP opinion for adult use in Europe; the once-weekly basal insulin icodec shows improved blood sugar reduction and safety profile, becoming a potential preferred treatment for type 2 diabetes
Published:
March 26, 2024
by Contify Life Science News
|
Novartis Canada disagrees with CADTH's draft recommendations not to reimburse LEQVIO for hypercholesterolemia treatment in Canada; Novartis claims LEQVIO has aided over 178,000 patients, including 2,000 Canadians, since 2022
Published:
March 26, 2024
by Contify Life Science News
|
Ask us about our Automobile Industry market view